ICL, PlantArcBio Partner on Biostimulants
ICL, Tel Aviv, andpublic ag-biotech company PlantArcBio, Ltd., Givat Hen, Israel, on July 19 announced the development of a novel biostimulant technology platform that they said will improve crop yields while having a minimal impact on the environment.
The platform successfully uses RNAi technology to maximize a plant’s natural yield increase mechanisms without any genetic modification, and was the result of a multi-year research collaboration between the two companies.
In early-stage canola field trials, the platform significantly increased seed weight per hectare for canola crops, according to the parties, who said they are planning larger-scale field trials in 2022. These will include testing the new technology platform using both commercial sprayers and standard farming practices. Greenhouse trials for soybeans and rice are already in progress, with early results showing good potential.
“The use of novel biostimulants based on RNAi technology helps promote sustainability, by reducing the use of chemicals in agriculture,” said Hadar Sutovsky, Vice President of External Innovation and General Manager of ICL Planet. “This aligns perfectly with ICL’s long-term goal of creating impact and sustainable growth in the agriculture end-market, alongside ensuring food security.
“ICL and PlantArcBio have filed for a joint patent on the application for multiple crops,” added Sutovsky. “The application does its work, then rapidly disappears from both the plants and the environment, lasting no more than a few days, as it is highly biodegradable and also leaves no residual footprint.”
“The positive canola field trial results constitute another milestone in strengthening PlantArcBio’s capabilities in the development of RNAi-based products,” said Dror Shalitin, Ph.D., founder and CEO of PlantArcBio. “ICL, a market leader in crop nutrition products, is a great strategic partner for us to commercialize this sustainable technology worldwide.”